•
The TPG-National Payor Roundtable (TPG-NPRT) focuses on market access programs within the United States and is a subsidiary of The Pharmacy Group. •
The JeSTARx Group provides evidence-based research and support to the Healthcare Industry. •
The TPG-NPRT maintains a proprietary database of Chief Medical Officers, Chief Pharmacy Officers and other key decision makers from health plans in the United States. • Comparative Effectiveness Research (CER) is an evolving discipline: -The first edition of ISPOR's Lexicon defined "effectiveness" as:
The degree to which a therapeutic outcome is achieved in a given patient population from a medical technology under actual or average conditions of use. 1 -ISPOR and the US Academy of Managed Care Pharmacy (AMCP), more recently defined "Comparative Effectiveness Research" (CER) as:
The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. The purpose of CER is to assist consumers, clinicians, purchasers, and policymakers to make informed decisions that will improve health care at both the individual and population levels. 2 
Objective and Purpose
• A total of 54 persons responded to the survey invitation (24.1% response rate).
•
Many advisors reported multiple degrees (Figure 1 ), and the most common degree was MD (55.6%).
Results
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• Formulary decision making in P&T committees is making progress in the use of comparative effectiveness research. •
The environment for P&T Committee decision making in managed care is undergoing a series of changes. • Payor medical directors and pharmacy directors, who commonly serve as P&T Committee members, have a distinct understanding and opinions as to how to alter the process to adapt to these influences.
•
Results suggest that the acceptance of evidence based medicine is valuable even if not comparative. This poster can be downloaded through the QR code; www.jestarx.com/publications/ or www.TPG-NPRT.com
Conclusions Disclosures: None
